A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy

Background: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) can detect multiparametric magnetic resonance imaging (mpMRI)-invisible prostate tumours and improve the sensitivity of detection of prostate cancer (PCa) in comparison to mpMRI alone. Num...

Full description

Bibliographic Details
Main Authors: Brian D. Kelly, Gideon Ptasznik, Matthew J. Roberts, Paul Doan, Phillip Stricker, James Thompson, James Buteau, Kenneth Chen, Omar Alghazo, Jonathan S. O'Brien, Michael S. Hofman, Mark Frydenberg, Nathan Lawrentschuk, Dara Lundon, Declan G. Murphy, Louise Emmett, Daniel Moon
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:European Urology Open Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168323002422